Dr Srikanth Muralikrishnan is a Senior Consultant, Hemato Oncology at Apollo Cancer Centre, Chennai. He has had extensive research experience in drug development of Multiple Myeloma & Pioneer Phase I & II trails of extensively Multiple Myeloma. He has been awarded MD (Research) by the prestigious Institute of cancer research at UK in partnership with Royal Mas Hospital, UK. He is also the recipient of the prestigious award of GCRS where in Royal Ma Hospital, UK.

Dr Srikanth Muralikrishnan had above 25 years of experience in the field of Hematology /Hemato Oncology. In view of the above research & clinical trials, He is able to Institute cutting edge therapy which includes newer Immunotherapy. & Targeted therapies. He has close links with the international experts in Europe & USA in delivering the cutting-edge therapies. He has multiple publications in internal journals. He has been a faculty member at various hematology conferences and has presented many papers at national and international level.